Improve the health of the people of Wisconsin by supporting and strengthening physicians' ability to practice high-quality patient care in a changing environment.

Policy Compendium

Policy Compendium Home

View Legal/Legislative Policies

DRU-016: Authorization for Field Use of Naloxone to Reduce Overdose

Authorization for Field Use of Naloxone to Reduce Overdose: The Wisconsin Medical Society (Society) supports development of enabling regulation and legislation, as necessary, to allow for evidence-based harm reduction strategies, along with physician and public education regarding these approaches, so that injectable naloxone or naloxone nasal spray may be readily available to persons who may be at risk of opioid overdose death, either in the context of authorized medical treatment of chronic pain or unauthorized use of heroin or prescription opioid analgesics by persons with substance use disorders. In order to meet this need, the Society supports reasonable and appropriate pricing of naloxone products such that cost does not create a barrier to use, and that access to naloxone is just and equitable. (HOD, 0416)